Alphatec Holdings (ATEC) Return on Capital Employed (2011 - 2026)
Alphatec Holdings (ATEC) reported Return on Capital Employed of 10.88% for Q1 2026, up 1114.0% on a YoY basis from 0.9% in Q1 2025, and up 24.45% sequentially from 14.41% in Q4 2025.
Alphatec Holdings (ATEC) Return on Capital Employed (2011 - 2026) Analysis & Trends
Alphatec Holdings (ATEC) has 16 years of Return on Capital Employed data on file, last reported at 10.88% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed rose 1114.0% year-over-year to 10.88%; the trailing twelve-month figure through Mar 2026 stood at 10.88% (up 1114.0% YoY), and the FY2025 full-year result was 14.55%, up 681.0% from the prior year.
- Return on Capital Employed climbed to 10.88% in Q1 2026, from 14.41% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 10.88% in Q1 2026 to a low of 38.7% in Q4 2022.
- A 5-year average of 27.52% and a median of 28.42% in 2024 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed sank 1312 bps in 2022 and jumped 1114 bps in 2026, its largest moves.
- Tracing ATEC's Return on Capital Employed over 5 years: stood at 38.7% in 2022, then gained by 23 bps to 29.89% in 2023, then climbed by 25 bps to 22.4% in 2024, then surged by 36 bps to 14.41% in 2025, then gained by 24 bps to 10.88% in 2026.
- Business Quant data shows ATEC's Return on Capital Employed at 10.88% in Q1 2026, 14.41% in Q4 2025, and 17.1% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Alphatec Holdings | 1.26 Bn | 1.12 Bn | 136.48 Mn | -10.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.88% |
| Dec 31, 2025 | -14.41% |
| Sep 30, 2025 | -17.10% |
| Jun 30, 2025 | -18.13% |
| Mar 31, 2025 | -22.02% |
| Dec 31, 2024 | -22.40% |
| Sep 30, 2024 | -26.15% |
| Jun 30, 2024 | -26.88% |
| Mar 31, 2024 | -28.42% |
| Dec 31, 2023 | -29.89% |
| Sep 30, 2023 | -32.64% |
| Jun 30, 2023 | -34.81% |
| Mar 31, 2023 | -36.30% |
| Dec 31, 2022 | -38.70% |
| Sep 30, 2022 | -38.62% |
| Jun 30, 2022 | -36.73% |
| Mar 31, 2022 | -33.80% |
| Dec 31, 2021 | -26.46% |
| Sep 30, 2021 | -25.50% |
| Jun 30, 2021 | -26.87% |